Results 171 to 180 of about 33,626 (230)

Protective role of fucoidan against cognitive deficits and redox imbalance in a scopolamine-induced Alzheimer's disease model in rats. [PDF]

Sci Rep
Salmani M, Anoush M, Kalantari-Hesari A, Jahani-Maleki A, Nouri F, Hosseini MJ, Mohammadi M.   +6 more
europepmc   +1 more source

<i>Lactobacillus delbrueckii</i> subsp. <i>lactis</i> CKDB001 Ameliorates Scopolamine-Induced Cognitive Impairment Through Metabolic Modulation. [PDF]

Int J Mol Sci
Kim H, Kim H, Lee Y, Park C, Cho B, Son S, Kim H, Kim G, Park J, Park H.   +9 more
europepmc   +1 more source

Evaluation of the neuroprotective activity of Momordica dioica against aluminum chloride (AlCl3)-Induced alzheimer's disease in Wistar rats. [PDF]

Discov Ment Health
Neve V, Saqlain S, Veeranjaneyulu A, Karwa P, Kapare H, Yeralkar K.   +5 more
europepmc   +1 more source

Cognitive stimulation exerts long-lasting protective effects on the hippocampal vasculature and memory function in a rat model of vascular cognitive impairment. [PDF]

NPJ Aging
Chapman AC, Thaqi A, Kalish RL, Deng B, DeMarco GM, Shehryar A, Baumoel EJ, Bergson P, Papavangjeli S.   +8 more
europepmc   +1 more source

Drug-Dependent Enhancement of Blood-Brain Barrier Permeation by Polysorbate 80 Minor Components. [PDF]

Pharmaceutics
Wang X, Wang J, Zhao X, Xie L, Yang R, Sun C, Tu J, Sun H.   +7 more
europepmc   +1 more source

Evaluation of the safety and efficacy of a donepezil depot injection in dogs with canine cognitive dysfunction. [PDF]

Front Vet Sci
Kang MH, Kang MA, Jeon HJ, Shin HC, Moon H, Lee DG, Park HM.   +6 more
europepmc   +1 more source

Pharmacokinetic Evaluation of GB-5001, a Long-Acting Injectable Formulation of Donepezil, in Healthy Korean Participants: Population Pharmacokinetics with Phase 1 Study. [PDF]

Pharmaceutics
Park YC, Seol E, Lee J, Hong JH, Jung JG, Sunwoo J.   +5 more
europepmc   +1 more source

Novel Bioinspired Quercetin-Based Polymers for the Sustained Release of Donepezil in Alzheimer's Disease Therapy. [PDF]

Polymers (Basel)
Carreiro EP, Múria P, Velez D, Carrott MR, Burke AJ, Costa AR.   +5 more
europepmc   +1 more source

Cholinesterase inhibitors in the treatment of Alzheimer's disease [PDF]

, 2013
Camps Cardenal, Laura, Universitat Autònoma de Barcelona. Facultat de Biociències   +1 more
core  

JAK4D, a first-in-class thyrotropin-releasing hormone analogue, reverses scopolamine-induced memory deficits. [PDF]

Brain Commun
McMackin R, Price S, Slator GR, Hardiman O, Kelly JA.   +4 more
europepmc   +1 more source